Colitis & Cancer: Why 8 to 10 Years Can Change the Conversation

Ulcerative colitis can make it difficult to know when a symptom needs fresh medical attention.

Blood, urgency, loose stools, abdominal pain, fatigue and changes in bowel habit can all be part of colitis. If you’ve lived with the condition for a while, it’s easy for symptoms to become part of the background. You may start judging everything against your own version of normal, even when that normal is already quite difficult.

That’s one reason bowel cancer surveillance matters.

For people with ulcerative colitis, bowel cancer risk can increase over time, particularly where inflammation affects more of the colon or remains active for long periods. The rough window often discussed in guidance is around 8 to 10 years after symptoms began, depending on the guidance used and the person’s individual risk factors.

That doesn’t mean cancer suddenly becomes likely at year eight. It means long-term inflammation can change the conversation, and patients should know when to ask about surveillance.

I only recently realised how important that question could be. Given some recent bowel issues, I’ll be raising it with my doctor rather than assuming every change is automatically “just colitis”.

The risk isn’t the same for everyone

The NHS says ulcerative colitis can increase the risk of bowel cancer, especially where the condition is severe or affects most of the colon.

Having ulcerative colitis doesn’t put everyone into the same risk category. Someone with proctitis, where inflammation is limited to the rectum, may be treated differently from someone with left-sided colitis or extensive colitis affecting much more of the colon.

Risk can also be affected by how long someone has had symptoms, how active the inflammation has been, whether they have primary sclerosing cholangitis, whether there’s a family history of bowel cancer, and whether previous colonoscopies have shown abnormal cell changes.

So the useful question isn’t only “do I have colitis?” It’s more specific than that. How much of the colon is affected? How long has it been going on? Has the inflammation been controlled? Have there been concerning findings before? Am I on the right surveillance plan?

Why 8 to 10 years comes up

NICE guidance says colonoscopic surveillance should be offered to people with inflammatory bowel disease whose symptoms started 10 years ago and who have ulcerative colitis, except proctitis alone, or Crohn’s colitis involving more than one segment of the colon.

British Society of Gastroenterology guidance has also discussed surveillance around 8 years after symptoms start for people with colonic inflammatory bowel disease. Newcastle University, writing about the updated BSG guideline, said one recommendation is that IBD patients should have a colonoscopy around eight years after their symptoms start, with patients who have primary sclerosing cholangitis needing colonoscopy at diagnosis.

The exact number can vary depending on the guidance, risk factors and local practice. The practical point for patients is simpler: if you’ve had ulcerative colitis symptoms for close to a decade, it’s worth asking whether bowel cancer surveillance applies to you.

The clock may also start from symptoms, not just the formal diagnosis date. That’s crucial. Many people have bowel symptoms for months or years before diagnosis. If you only count from the diagnosis letter, you may miss part of the story.

Colitis can blur the warning signs

One of the difficult parts is that bowel cancer symptoms can overlap with colitis symptoms.

The NHS lists bowel cancer symptoms including changes in poo, needing to poo more or less often than usual, blood in poo, bleeding from the bottom, tummy pain, bloating, unexplained weight loss and tiredness.

If you already have ulcerative colitis, some of that may sound familiar.

That overlap is exactly why patients shouldn’t be left to work this out alone. If someone with colitis has blood, diarrhoea, urgency, fatigue or abdominal pain, it can be tempting to assume it’s their usual pattern. Sometimes that may be right. Sometimes it needs checking.

Patients need clearer thresholds. “Come back if it gets worse” isn’t always helpful when someone’s baseline already includes unpredictable bowel symptoms. It’s better to ask what changes should trigger review, such as more bleeding than usual, a different type of pain, night symptoms, weight loss, anaemia, or symptoms that persist beyond your normal flare pattern.

Symptom management isn’t the same as surveillance

I’ve written before about different ways people try to manage ulcerative colitis and chronic gut symptoms. That includes glutamine, cannabis treatment, food triggers and the FODMAP diet.

Those topics can be useful, but they sit in a different lane from bowel cancer surveillance.

A food diary can help you spot patterns. A supplement may be worth discussing with a clinician. Cannabis may help some patients with symptoms. A FODMAP approach may help some people identify foods that worsen bloating, urgency or discomfort.

But none of those things inspect the bowel lining. None of them check for early abnormal cell changes. None of them replace medical review where surveillance is clinically relevant.

That distinction needs to be clear because people with chronic illness often end up building their own survival toolkit. That can be helpful, especially when services are slow or dismissive, but it shouldn’t replace the main clinical safety questions.

This is also about privacy and dignity

Bowel symptoms are embarrassing for a lot of people. That can make it harder to raise concerns early.

If someone has to explain bleeding, urgency, diarrhoea or accidents through a reception desk, a public pharmacy counter, or a rushed appointment system, they may hold back. That can delay care.

I’ve written before about privacy in NHS pharmacy and GP reception settings because sensitive health information often gets pushed into places where patients don’t feel comfortable speaking openly.

With colitis, that privacy problem isn’t cosmetic. If embarrassment stops someone saying “my bleeding has changed” or “I’m going to the toilet far more than usual”, that can affect whether they’re checked properly.

Patients should be able to raise bowel symptoms privately, clearly and without feeling like they’re making a fuss.

The simple version

If you’ve had ulcerative colitis symptoms for around 8 to 10 years, especially if your colitis affects more than just the rectum, ask your GP, IBD nurse or gastroenterology team whether bowel cancer surveillance applies to you.

That doesn’t mean cancer is likely.

It means long-term inflammation can change your risk, and you deserve a clear plan instead of guesswork.

The key thing is not to assume someone else will explain it perfectly. They might not. The system often assumes patients know things they were never actually told.

If your symptoms have changed, raise it. If you don’t know when your surveillance should start, ask. If you’re reassured, ask what that reassurance is based on. If you’re due a check, get it moving.

Chronic illness already creates enough uncertainty. The basic safety plan shouldn’t be another mystery.